SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 129.61 |
| Enterprise Value ($M) | 24.01 |
| Book Value ($M) | 382.82 |
| Book Value / Share | 1.30 |
| Price / Book | 0.34 |
| NCAV ($M) | 271.56 |
| NCAV / Share | 0.92 |
| Price / NCAV | 0.48 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.78 |
| Return on Assets (ROA) | -0.49 |
| Return on Equity (ROE) | -0.57 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.06 |
| Current Ratio | 7.06 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 379.59 |
| Assets | 490.86 |
| Liabilities | 108.03 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.06 |
| Operating Income | -218.93 |
| Net Income | -342.99 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -162.39 |
| Cash from Investing | 122.42 |
| Cash from Financing | 1.33 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | ARCH Venture Fund IX, L.P. | 13.10 | 0.33 | |
| 13G/A | Foresite Capital Fund IV, L.P. | 6.70 | 42.35 | |
| 13G/A | BlackRock, Inc. | 4.50 | -7.25 | |
| 13G/A | Vanguard Group Inc | 3.93 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 397,193 | 966,863 | 41.08 | |
| 231,035 | 583,699 | 39.58 | |
| 250,774 | 881,777 | 28.44 | |
| 135,729 | 363,709 | 37.32 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| KYTX – Kyverna Therapeutics, Inc. | LVTX – LAVA Therapeutics N.V. |
| LXRX – Lexicon Pharmaceuticals, Inc. | MCRB – Seres Therapeutics, Inc. |
| MDGL – Madrigal Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io